Travere Therapeutics Named Finalist for the 2022 PM360 Magazine Trailblazer Specialty Pharma/Biotech Company of the Year Award
Wednesday, August 17, 2022 — We are thrilled to have been named as a finalist for the 2022 PM30 Magazine Trailblazer Specialty Pharma/Biotech Company of the Year award. Trailblazer finalists are selected by a cross-section of experts from across the industry evaluating companies for innovation, talent development, and social responsibility. Read the full list of finalists.